Insider · CIK 0001422304
Jane Henderson
cfoofficerdirector
Files at AKRO (Akero Therapeutics, Inc.), CRGX (CARGO Therapeutics, Inc.), APGE (Apogee Therapeutics, Inc.). First filing Aug 12, 2025, latest Aug 12, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $142k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Akero Therapeutics, Inc. | $142k 3,000 shares | -24% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Common Stock | -158,371 | - | - | 0 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -175,345 | - | - | 0 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -124,962 | - | - | 0 | 39 d ago |
| Sep 3, 2026 | APGE Apogee Therapeutics, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -83,690 | - | - | 0 | 39 d ago |
| Aug 12, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Common Stock | +3,000 | $7.01 | $21k | 12,398 | Aug 12, 2025 |
| Aug 12, 2025 | AKRO Akero Therapeutics, Inc. | SOpen-market sale Common Stock | -3,000 | $47.46 | $142k | 9,398 | Aug 12, 2025 |
| Aug 12, 2025 | AKRO Akero Therapeutics, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -3,000 | $0.00 | $0 | 11,797 | Aug 12, 2025 |
| Jun 18, 2025 | CRGX CARGO Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 20, 2025 |
| Jun 3, 2025 | AKRO Akero Therapeutics, Inc. | AGrant or award Common Stock | +9,398 | $0.00 | $0 | 9,398 | Jun 5, 2025 |
| Dec 9, 2024 | APGE Apogee Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +124,962 | $0.00 | $0 | 124,962 | Dec 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.